While studies have suggested biomarkers like BNP and homocysteine as reliable predictors for AF ablation outcomes, there remains no consensus among electrophysiologists on their integration with clinical scoring systems [15, 21, 22]. This evidence concerns the gene NPPB and atrial fibrillation.